SecurityGLBL / TerraForm Global, Inc. (88104M101)
Institutional Owners20 (14 N-Q Owners)
Institutional Shares2,202,055 - 1.27% (ex. N-Q)
Shares Outstanding173,192,913 shares (as of 2017-09-30)
Institutional Value$ 10,202,000 USD (ex. N-Q)

Institutional Stock Ownership and Shareholders

TerraForm Global, Inc. (NASDAQ:GLBL) has 20 institutional investors and shareholders that have filed 13D/G or 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 2,202,055 shares. Largest shareholders include Oxford Asset Management, Walleye Trading LLC, Norges Bank, Russell Investments Group, Ltd., Quad Capital Management Advisors LLC, and Simplex Trading, Llc.

TerraForm Global, Inc. (NASDAQ:GLBL) ownership summary shows current positions in the company by institutions and funds, as well as latest changes in position size. Major shareholders can include individual investors, mutual funds, hedge funds, or institutions. The Schedule 13D indicates that the investor holds more than 5% of the company and intends to actively pursue a change in business strategy. Schedule 13G indicates a passive investment of over 5%. Green rows indicate new positions. Red rows indicate closed positions. Click the link icon to see the full transaction history.


File DateFormInvestor Opt Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
($1000)
Current Value
($1000)
Change
(Percent)
2017-11-28 N-Q Usaa Mutual Funds Trust (see advisory)
2018-01-10 13F-HR SIMPLEX TRADING, LLC Put 273 638 133.70 36 1 -97.22
2018-02-13 13F-HR AMALGAMATED BANK 11,041 0 -100.00 52 0 -100.00
2018-02-14 13F-HR D. E. Shaw & Co., Inc. 11,275 0 -100.00 54 0 -100.00
2018-02-14 13F-HR GUGGENHEIM CAPITAL LLC 1,117,750 0 -100.00 5,309 0 -100.00
2018-02-06 13F-HR Russell Investments Group, Ltd. 169,000 858
2018-02-14 13F-HR MORGAN STANLEY 353,533 0 -100.00 1,679 0 -100.00
2017-11-14 13F-HR CAPSTONE INVESTMENT ADVISORS, LLC 47,635 0 -100.00 240 0 -100.00
2018-02-02 13F-HR GAMCO INVESTORS, INC. ET AL 156,313 0 -100.00 742 0 -100.00
2017-11-14 13F-HR SUSQUEHANNA INTERNATIONAL GROUP, LLP 53,358 0 -100.00 270 0 -100.00
2017-11-22 N-Q Quantitative Master Series Llc (see advisory)
2018-01-17 13F-HR SCHWAB CHARLES INVESTMENT MANAGEMENT INC 325,459 0 -100.00 1,546 0 -100.00
2017-11-09 13F-HR TFS CAPITAL LLC 38,229 0 -100.00 193 0 -100.00
2017-11-29 N-Q Gabelli Investor Funds Inc (see advisory)
2018-02-14 13F-HR TUDOR INVESTMENT CORP ET AL 44,809 0 -100.00 213 0 -100.00
2018-02-14 13F-HR BAMCO INC /NY/ 2,444,797 0 -100.00 11,613 0 -100.00
2018-02-08 13F-HR SEI INVESTMENTS CO 22 0 -100.00 0 0
2018-02-14 13F-HR Invesco Ltd. 145,023 0 -100.00 689 0 -100.00
2018-01-17 13F-HR HAVENS ADVISORS LLC 178,000 0 -100.00 846 0 -100.00
2018-02-14 13F-HR WOLVERINE ASSET MANAGEMENT LLC 512,177 0 -100.00 2,432 0 -100.00
2018-02-02 13F-HR GABELLI FUNDS LLC 1,453,932 0 -100.00 6,906 0 -100.00
2018-01-10 13F-HR SIMPLEX TRADING, LLC 8,514 0 -100.00 40 0 -100.00
2018-02-12 13F-HR OPPENHEIMER FUNDS INC 237,625 0 -100.00 1,129 0 -100.00
2018-02-01 13F-HR Nationwide Fund Advisors 49,315 0 -100.00 234 0 -100.00
2017-10-13 13F-HR NISA INVESTMENT ADVISORS L.L.C. 26,600 0 -100.00 130 0 -100.00
2017-10-25 13F-HR SIMPLEX TRADING, LLC Call 56 0 -100.00 13 0 -100.00
2018-02-09 13F-HR AMERICAN INTERNATIONAL GROUP INC 59,855 0 -100.00 284 0 -100.00
2017-11-27 N-Q Westchester Capital Funds (see advisory)
2018-02-14 13F-HR MENTA CAPITAL LLC 30,348 0 -100.00 144 0 -100.00
2017-11-14 13F-HR GAM Holding AG 220,451 0 -100.00 1,113 0 -100.00
2018-02-14 13F-HR Ameritas Investment Partners, Inc. 7,121 0 -100.00 35 0 -100.00
2018-02-14 13F-HR Telemetry Investments, L.L.C. 238,139 0 -100.00 1,131 0 -100.00
2018-02-14 13F-HR TEACHERS ADVISORS INC 162,253 0 -100.00 771 0 -100.00
2018-02-14 13F-HR Perella Weinberg Partners Capital Management LP 115,179 0 -100.00 547 0 -100.00
2018-01-17 13F-HR Cutler Group LP Put 100 0 -100.00 0 0
2018-02-07 13F-HR Swiss National Bank 137,032 0 -100.00 651 0 -100.00
2018-02-09 13F-HR BlackRock Inc. 5,489,527 0 -100.00 26,074 0 -100.00
2018-02-16 13F-HR/A-1 OXFORD ASSET MANAGEMENT 1,417,142 1,417,142 0.00 7,157 6,731 -5.95
2018-02-12 13F-HR CITIGROUP INC 168 0 -100.00 1 0 -100.00
2017-11-09 13F-HR VAN ECK ASSOCIATES CORP 61,367 0 -100.00 310 0 -100.00
2017-11-14 13F-HR TWO SIGMA SECURITIES, LLC 23,756 0 -100.00 120 0 -100.00
2018-02-13 13F-HR OMERS ADMINISTRATION Corp 1,683,149 0 -100.00 7,995 0 -100.00
2018-02-14 13F-HR PARAMETRIC PORTFOLIO ASSOCIATES LLC 133,167 0 -100.00 633 0 -100.00
2018-02-14 13F-HR ROYAL BANK OF CANADA 8,650 0 -100.00 41 0 -100.00
2017-09-29 N-Q Neuberger Berman Alternative Funds (see advisory)
2018-02-14 13F-HR DEUTSCHE BANK AG\ 592,312 0 -100.00 2,812 0 -100.00
2018-02-08 13F-HR WELLS FARGO & COMPANY/MN 100,783 0 -100.00 509 0 -100.00
2018-02-14 13F-HR CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM 141,985 0 -100.00 674 0 -100.00
2018-02-12 13F-HR STONEHILL CAPITAL MANAGEMENT LLC 1,050,000 0 -100.00 4,988 0 -100.00
2018-02-14 13F-HR BlueCrest Capital Management Ltd Call 16,900 0 -100.00 80 0 -100.00
2017-11-13 13F-HR Spark Investment Management LLC 310,500 0 -100.00 1,568 0 -100.00
2018-01-24 13F-HR FNY Partners Fund LP 30,068 0 -100.00 142 0 -100.00
2017-09-28 N-Q Fidelity Salem Street Trust (see advisory)
2018-02-13 13F-HR GEODE CAPITAL MANAGEMENT, LLC 597,745 0 -100.00 2,839 0 -100.00
2018-02-13 13F-HR COMMONWEALTH OF PENNSYLVANIA PUBLIC SCHOOL EMPLS RETRMT SYS 988,548 0 -100.00 4,696 0 -100.00
2018-02-12 13F-HR HRT FINANCIAL LLC 20,300 0 -100.00 96 0 -100.00
2018-01-29 N-Q Claymore Exchange-traded Fund Trust 2 (see advisory)
2018-02-09 13F-HR Bank of New York Mellon Corp 468,561 0 -100.00 2,225 0 -100.00
2018-02-06 13F-HR CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM 56,400 0 -100.00 268 0 -100.00
2018-02-14 13F-HR FAIRFAX FINANCIAL HOLDINGS LTD/ CAN 300,000 0 -100.00 1,410 0 -100.00
2018-02-14 13F-HR MILLENNIUM MANAGEMENT LLC 29,081 0 -100.00 138 0 -100.00
2018-02-13 13F-HR Quinn Opportunity Partners LLC 35,000 0 -100.00 166 0 -100.00
2017-11-14 13F-HR Banco BTG Pactual S.A. 1,611,106 0 -100.00 8,136 0 -100.00
2018-02-14 13F-HR Voya Investment Management LLC 47,874 0 -100.00 227 0 -100.00
2018-02-14 13F-HR SUSQUEHANNA INTERNATIONAL GROUP, LLP Put 10,000 0 -100.00 48 0 -100.00
2018-02-14 13F-HR BANK OF AMERICA CORP /DE/ 16,613 0 -100.00 79 0 -100.00
2018-02-14 13F-HR Polar Asset Management Partners Inc. 100,000 0 -100.00 475 0 -100.00
2017-10-23 13F-HR MIZUHO SECURITIES USA INC. 792,348 0 -100.00 4,001 0 -100.00
2018-02-02 13F-HR GABELLI SECURITIES, INC. 2,350,819 0 -100.00 11,166 0 -100.00
2017-09-29 N-Q Dunham Funds (see advisory)
2017-11-14 13F-HR WHITEBOX ADVISORS LLC 114,845 0 -100.00 580 0 -100.00
2017-10-17 13F-HR Cutler Group LP 40,480 0 -100.00 204 0 -100.00
2018-01-23 13F-HR STRS OHIO 13,500 0 -100.00 64 0 -100.00
2018-02-14 13F-HR AQR CAPITAL MANAGEMENT LLC 31,435 0 -100.00 149 0 -100.00
2018-02-01 13F-HR Engineers Gate Manager LP 46,153 0 -100.00 219 0 -100.00
2018-02-14 13F-HR BARCLAYS PLC 237,518 0 -100.00 1,128 0 -100.00
2018-02-08 13F-HR ALPINE ASSOCIATES MANAGEMENT INC. 4,736,620 0 -100.00 22,499 0 -100.00
2017-11-29 N-Q Rydex Series Funds (see advisory)
2018-02-13 13F-HR NEW YORK STATE COMMON RETIREMENT FUND 82,100 0 -100.00 390 0 -100.00
2018-02-14 13F-HR SPRINGBOK CAPITAL MANAGEMENT, LLC 18,300 0 -100.00 87 0 -100.00
2018-02-13 13F-HR Legal & General Group Plc 25,830 0 -100.00 122 0 -100.00
2018-02-01 13F-HR STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM 27,240 0 -100.00 129 0 -100.00
2018-01-16 13F-HR BANK OF MONTREAL /CAN/ 18,304 0 -100.00 87 0 -100.00
2018-02-14 13F-HR PANAGORA ASSET MANAGEMENT INC 194,434 0 -100.00 923 0 -100.00
2018-02-02 13F-HR Aperio Group, LLC 49,667 0 -100.00 236 0 -100.00
2018-02-12 13F-HR DIMENSIONAL FUND ADVISORS LP 51,610 0 -100.00 245 0 -100.00
2018-02-05 13F-HR Kassirer Asset Management Corp 71,500 0 -100.00 340 0 -100.00
2017-11-27 N-Q Baron Select Funds (see advisory)
2018-01-12 SC 13D/A Knighthead Capital Management, LLC 9,203,400 0 -100.00
2018-03-14 13F-HR/A-1 CREDIT SUISSE AG/ 195,109 0 -100.00 926 0 -100.00
2018-02-12 13F-HR PRINCIPAL FINANCIAL GROUP INC 12,169 0 -100.00 58 0 -100.00
2018-02-15 13F-HR/A-1 BROOKFIELD ASSET MANAGEMENT INC. 19,536,004 0 -100.00 92,796 0 -100.00
2018-02-09 13F-HR Virtu Financial LLC 12,642 0 -100.00 60 0 -100.00
2018-02-14 13F-HR GSA CAPITAL PARTNERS LLP 37,816 0 -100.00 180 0 -100.00
2018-02-14 13F-HR VANGUARD GROUP INC 1,985,959 0 -100.00 9,433 0 -100.00
2018-02-13 13F-HR Renaissance Technologies LLC 1,765,157 0 -100.00 8,384 0 -100.00
2018-02-08 13F-HR PUBLIC EMPLOYEES RETIREMENT SYSTEM OF OHIO 132,000 0 -100.00 627 0 -100.00
2017-11-14 13F-HR Walleye Trading LLC 382,573 337,158 -11.87 1,932 1,602 -17.08
2018-02-14 13F-HR TORTOISE CAPITAL ADVISORS, L.L.C. 5,000 0 -100.00 24 0 -100.00
2018-01-31 13F-HR Overland Advisors, LLC 2,777,380 0 -100.00 13,193 0 -100.00
2018-02-14 13F-HR BlueCrest Capital Management Ltd 15,999 0 -100.00 76 0 -100.00
2018-02-09 13F-HR RHUMBLINE ADVISERS 98,983 0 -100.00 470 0 -100.00
2018-02-13 13F-HR JP Morgan Chase & Co 332,214 0 -100.00 1,578 0 -100.00
2018-01-24 13F-HR SG Americas Securities, LLC 1,140,247 0 -100.00 5,416 0 -100.00
2018-02-09 13F-HR GREAT WEST LIFE ASSURANCE CO /CAN/ 20,898 0 -100.00 98 0 -100.00
2018-02-14 13F-HR Sather Financial Group Inc 102,550 0 -100.00 487 0 -100.00
2018-02-08 13F-HR MANUFACTURERS LIFE INSURANCE COMPANY, THE 75,157 0 -100.00 357 0 -100.00
2018-02-14 13F-HR Natixis 11,159 0 -100.00 53 0 -100.00
2018-02-13 13F-HR Allianz Asset Management AG 661,893 0 -100.00 3,144 0 -100.00
2018-02-14 13F-HR Quad Capital Management Advisors LLC 21,099 0
2017-11-13 13F-HR/A-1 NORGES BANK 300,000 257,656 -14.11 978 1,011 3.37
2018-02-14 13F-HR UBS Group AG 22,505 0 -100.00 107 0 -100.00
2018-02-14 13F-HR Westchester Capital Management, LLC 569,722 0 -100.00 2,707 0 -100.00
2018-02-12 13F-HR DLD Asset Management, LP 20,795 0 -100.00 99 0 -100.00
2018-01-17 13F-HR Cutler Group LP Call 14,000 0 -100.00 0 0
2017-11-14 13F-HR GROUP ONE TRADING, L.P. Put 400 0 -100.00 2 0 -100.00
2018-03-05 13F-HR/A-1 BNP PARIBAS ARBITRAGE, SA 8,970 0 -100.00 42,608 0 -100.00
2018-02-14 13F-HR EVENTIDE ASSET MANAGEMENT, LLC 160,000 0 -100.00 760 0 -100.00
2018-02-14 13F-HR NORTHERN TRUST CORP 953,619 0 -100.00 4,530 0 -100.00
2018-02-09 13F-HR UBS ASSET MANAGEMENT AMERICAS INC 41,600 0 -100.00 197,600 0 -100.00
2017-09-28 N-Q Vanguard Trustees' Equity Fund (see advisory)
2017-11-13 13F-HR Hgc Investment Management Inc. 151,600 0 -100.00 766 0 -100.00
2017-11-29 N-Q Gdl Fund (see advisory)
2018-02-14 13F-HR BALYASNY ASSET MANAGEMENT LLC 86,643 0 -100.00 412 0 -100.00
2017-11-14 13F-HR Connor, Clark & Lunn Investment Management Ltd. 16,100 0 -100.00 81 0 -100.00
2018-02-13 13F-HR ALLIANCEBERNSTEIN L.P. 129,633 0 -100.00 616 0 -100.00
2018-02-14 13F-HR Linden Advisors LP 2,507,137 0 -100.00 11,909 0 -100.00
2018-02-12 13F-HR DUMAC, INC. 300,000 0 -100.00 1,425 0 -100.00
2018-02-14 13F-HR Alpine Partners VI, LLC 200,000 0 -100.00 950 0 -100.00
2018-02-14 13F-HR GOLDMAN SACHS GROUP INC 92,887 0 -100.00 441 0 -100.00
2018-01-22 SC 13D/A GARDNER LEWIS ASSET MANAGEMENT L P 9,476,139 0 -100.00
2018-01-26 N-Q Fidelity Concord Street Trust (see advisory)
2018-02-14 13F-HR CANNELL CAPITAL LLC 20,408 0 -100.00 97 0 -100.00
2018-02-14 13F-HR Ancora Advisors, LLC 235,854 0 -100.00 1,120 0 -100.00
2017-11-14 13F-HR Paloma Partners Management Co 38,332 0 -100.00 193 0 -100.00
2018-02-09 13F-HR GROUP ONE TRADING, L.P. Call 50,000 0 -100.00 238 0 -100.00
2018-02-13 13F-HR PRUDENTIAL FINANCIAL INC 12,130 0 -100.00 58 0 -100.00
2018-02-14 13F-HR TIAA CREF INVESTMENT MANAGEMENT LLC 218,734 0 -100.00 1,039 0 -100.00
2018-02-14 13F-HR STATE STREET CORP 1,640,548 0 -100.00 7,793 0 -100.00
2018-02-09 13F-HR TCW GROUP INC 736,200 0 -100.00 3,497 0 -100.00
2018-02-14 13F-HR QUENTEC ASSET MANAGEMENT LLC 4,161,679 0 -100.00 19,768 0 -100.00
2017-11-15 13F-HR WOLVERINE TRADING, LLC Put 36,000 0 -100.00 180 0 -100.00
2017-11-29 N-Q Mutual Fund Series Trust (see advisory)
2017-11-14 13F-HR Squarepoint Ops LLC 10,500 0 -100.00 53 0 -100.00

Form N-Q Advisory - Experimental Feature Here!

We have recently started to include coverage of N-Q filers in our ownership database. N-Q forms are unstructured and difficult for machines to parse into accurate financial data.

However, Because of the large number of these institutions and this difficulty in tracking their positions, they represent a significant, yet hidden, market force. In an effort to widen our ownership coverage and provide greater transparency, we are testing various ways to expose these owners in an accurate manner. This early version of the crawler simply identifies mentions of companies in the N-Q forms.

Limitations:

  • We only list underlying securities (the ordinary shares), even though the actual security held might be a derivative or a related bond issue. For example, although the institution is shown on this security page ( GLBL / TerraForm Global, Inc. ), the institution may actually own a related security such as a preferred share or a bond. To find out the exact security, click on the institution link and then follow the link to the actual "N-Q".
  • We only list fund sponsors as institutions, even though the security might be held within a fund operated by the listed institution.. For example, the institution listed in the table as the owner is probably a sponsor of a family of ETFs or mutual funds. If so, then this security is owned by a fund or several funds within the family, and not directly owned by the listed institution. The crawler is not yet able to place these holdings within the individual funds. Atain, you must review the actual filing to see the detail.

These limitations are significant but we believe that the increased transparency outweights the limitations. Future revisions of the crawler will resolve these limitations. Use this information at your own risk!

Related Articles

RDHL: Redhill Biopharma Ltd (OTC:REDIF) Analysis and Research Report

2018-04-18 - Asif

History and Development of the Company The company's legal and commercial name is RedHill Biopharma Ltd. The company's company was incorporated on August 3, 2009, and was registered as a private company limited by shares under the laws of the State of Israel. The company's principal executive offices are located at 21 Ha’arba’a Street, Tel Aviv, Israel. In February 2011, the company completed its initial public offering in Israel, pursuant to which the company issued 14,302,300 Ordinary Shares, and 7,151,150 tradable Series 1 Warrants to purchase 7,151,150 Ordinary Shares for aggregate gross proceeds of approximately $14 million. On December 27, 2012, the company completed the listing of its ADSs on the NASDAQ Capital Market. The company's Ordinary Shares are traded on the Tel-Aviv Stock Exchange under the symbol “RDHL,” and its ADSs are traded on the NASDAQ Capital Market under the same symbol "RDHL". The company's capital expenditures for the years ended December 31, 2...

SCYX: SCYNEXIS Analysis and Research Report

2018-04-16 - Asif

Overview SCYNEXIS, Inc. is a biotechnology company committed to positively impacting the lives of patients suffering from difficult-to-treat and often life-threatening infections by delivering innovative anti-infective therapies. SCYNEXIS is developing its lead product candidate, SCY-078, as the first representative of a novel oral and intravenous (IV) triterpenoid antifungal family in clinical development for the treatment of several serious fungal infections, including invasive candidiasis, invasive aspergillosis, refractory invasive fungal infections and vulvovaginal candidiasis (VVC). SCY-078 is a structurally distinct glucan synthase inhibitor that has been shown to be effective in vitro and in vivo against a broad range of human fungi pathogens such as Candida and Aspergillus species, including multidrug-resistant strains, as well as Pneumocystis species. Candida and Aspergillus species are the fungi responsible for approximately 85% of all invasive fungal infections in t...

ENRT: Enertopia Corp (CNSX:TOP) Analysis and Research Report

2018-04-16 - Asif

Business History Enertopia Corp. was formed on November 24, 2004 under the laws of the State of Nevada and commenced operations on November 24, 2004. From inception until April 2010, the company were primarily engaged in the acquisition and exploration of natural resource properties. Beginning in April 2010, the company began its entry into the renewable energy sector by purchasing an interest in a solar thermal design and installation company. In late summer 2013, the company began its entry into medicinal marijuana business. During its 2014 fiscal year end its activities in the clean energy sector were discontinued. During fiscal 2015 its activities in the Medicinal Marijuana sector were discontinued. During fiscal 2016 its activities in the Women’s personal healthcare sector were discontinued. The Company is actively pursuing business opportunities in the resource sector, whereby the company signed a definitive agreement for a Lithium Brine Project in May 2016. In May ...

FB: Facebook Analysis and Research Report

2018-04-15 - Asif

Overview The company's mission is to give people the power to build community and bring the world closer together. The company's top priority is to build useful and engaging products that enable people to connect and share with friends and family through mobile devices, personal computers, and other surfaces. The company also help people discover and learn about what is going on in the world around them, enable people to share their opinions, ideas, photos and videos, and other activities with audiences ranging from their closest friends to the public at large, and stay connected everywhere by accessing its products, including: Facebook enables people to connect, share, discover, and communicate with each other on mobile devices and personal computers. There are a number of different ways to engage with people on Facebook, the most important of which is News Feed which displays an algorithmically-ranked series of stories and advertisements individualized for each pers...

VSTM: Verastem Analysis and Research Report

2018-04-12 - Asif

Business Overview Verastem is a biopharmaceutical company focused on developing and commercializing drugs to improve the survival and quality of life of cancer patients. The company's most advanced product candidates, duvelisib and defactinib, utilize a multi-faceted approach to treat cancers originating either in the blood or major organ systems. Verastem is currently evaluating these compounds in both preclinical and clinical studies as potential therapies for certain cancers, including leukemia, lymphoma, lung cancer, ovarian cancer, mesothelioma, and pancreatic cancer. The company believe that these compounds may be beneficial as therapeutics either as single agents or when used in combination with immuno-oncology agents or other current and emerging standard of care treatments in aggressive cancers that are poorly served by currently available therapies. Duvelisib targets the Phosphoinositide 3-kinase (PI3K) signaling pathway. The PI3K signaling pathway plays a centr...

CUSIP: 88104M101